Phoenix, Arizona Clinical Trials

A listing of Phoenix, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
Smoke Testing v6.14.1  

Testing

Test Site 3
 (0.2 away)
  • 0 views
  • 14 Jun, 2024
  • +5 other locations
Caterpillar Arterial Embolization Device Post-Market Study

The primary objective of this study is to evaluate the performance and safety of the Caterpillar Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.

Dignity Health/St. Joseph's & Medical Center
 (4.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX

Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: To characterize the long-term efficacy of fitusiran as assessed by the frequency of: Bleeding episodes Spontaneous bleeding episodes Target joint bleeding episodes To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants …

haemophilia a
fitusiran
antihemophilic factor
hemarthrosis
hemophilia
Investigational Site Number 8400009
 (5.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +43 other locations
manual trial test  

manual trial test overview

Test Site 3
 (0.2 away)
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
dementia
pick's disease
progranulin
Dignity Health
 (4.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

ly573144
preventive medication
lasmiditan
headache
treatment regimen
21st Century Neurology
 (0.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

mini-mental state examination
flortaucipir
alzheimer's disease
positron emission tomography
florbetapir
Banner Alzheimer's Institute
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
Infigratinib in Recurrent Glioblastoma Patients

This trial is an open-label, multicenter, Phase 0 trial that will enroll up to 20 participants with recurrent high-grade glioma with FGFR1 K656E or FGFR3 K650E mutation or FGFR3-TACC3 translocation which are scheduled for resection. In the lead-in cohort, a total of 20 participants will be enrolled into the proposed …

peripheral neuropathy
glioblastoma multiforme
glioma
infigratinib
calcium
St. Joseph's Hospital and Medical Center
 (4.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Nutritional Study of Fish Oil in Skin Quality in Healthy Women test 22222 (OPTIHUD)  

test sync --- The skin acts as a barrier against the external environment and prevents water loss from the body. Aging is a natural process leading to changes in the skin and fish oil has been shown to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine skin characteristics …

Accepts healthy volunteers
Test Site 3
 (0.2 away)
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Virtual Trail 03

Test Comment here

Test Site 3
 (0.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations